Back to Top
Flanvotumab Biosimilar - Research Grade
$710.00 - $6,900.00
Flanvotumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
TYRP1ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P17643
Shipping Conditions
Blue ice
Background
Tyrosinase-related protein 1 (TYRP1) is a melanosomal enzyme and a surface antigen on melanocytes and melanoma cells, making it a target of interest in melanoma research. The research-grade anti-TYRP1 recombinant monoclonal antibody provided here is an unconjugated, non-therapeutic analog of flanvotumab, intended for research use only (RUO). Produced to demanding in vivo standards, the low-endotoxin, ultra-pure formulation is available in scalable milligram (mg) to gram (g) quantities to support heavy-usage laboratories. It is suitable for tumor-targeting studies, ADCC assays, in vivo melanoma models, and biologics characterization.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












